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PERKAITAN ANTARA STATUS PEMAKANAN DENGAN ARAS HORMON 
LEPTIN SERUM DALAM KALANGAN PESAKIT BARU KANSER PAYUDARA 
DI HOSPITAL UNIVERSITI SAINS MALAYSIA (HOSPITAL USM): KAJIAN 
KES-KAWALAN 
ABSTRAK 
Kadar insidens penyakit kanser payudara sedang meningkat di seluruh dunia. Di 
Malaysia, kanser payudara merupakan kanser yang paling ramai dihidapi oleh wanita 
merangkumi 29.9% daripada kes kanser yang baru. Malah, berdasarkan laporan daripada 
Daftar Kanser Kebangsaan (NCR), pada tahun 2006, sebanyak 3525 wanita menghidap 
kanser payudara di negara ini. Terdapat banyak kajian yang melaporkan bahawa 
berlebihan berat badan akan meningkatkan risiko mendapat kanser payudara dan individu 
yang gemuk mempunyai aras hormon leptin serum yang tinggi berbanding individu yang 
mempunyai berat badan normal. Tujuan kajian ini dijalankan adalah untuk melihat 
hubungan antara status pemakanan dan aras hormon leptin dalam kalangan pesakit kanser 
payudara baru di Hospital USM. Kajian berbentuk kes kawalan ini melibatkan seramai 46 
orang pesakit kanser payudara yang baru didiagnos serta belum menerima sebarang terapi 
kanser dan 46 orang kumpulan kawalan berumur dalam lingkungan 20 hingga 70 tahun. 
Parameter yang digunakan dalam kajian untuk menilai pengambilan makronutrien ialah 
Ingatan Diet 1 Hari (1DDR), antropometri (berat, tinggi, indeks jisim tubuh (IJT) & 
ukurlilit pinggang dan pinggul) dan komposisi tubuh dengan menggunakan impedans bio-
elektrikal (BIA). Aras hormon leptin serum diukur dengan kaedah ‘immunoassay’ 
menggunakan Human Leptin ELISA Kit (AssayMax Human Leptin, Cat.No:EL2001-1; 
 xiv 
 
AssayPro, USA). Setiap subjek kajian akan diambil keizinan bagi menyertai kajian ini. 
Secara keseluruhanya, kajian ini mendapati wanita yang mengalami haid yang awal 
(sebelum umur 12 tahun) dan pos menopaus masing-masing berisiko 3 kali ganda untuk 
mendapat kanser payudara berbanding wanita yang datang haid selepas umur 12 tahun 
[ORKasar=2.9 (95% CI=0.2-1.0)] (p < 0.05) dan pra menopaus [OR Kasar=3.0 (95% 
CI=1.2-7.0)] (p < 0.05). Indeks Jisim Tubuh (IJT) antara pesakit kanser payudara (24.5 ± 
3.8 kg/m2) dengansubjek kawalan (23.2 ± 4.8 kg/m2) tidak berbeza secara signifikan. 
Peratusan lemak tubuh yang diukur dengan kaedah BIA menunjukkan perbezaan 
signifikan iaitu pesakit kanser payudara mempunyai aras lemak yang tinggi (36.2 ± 8.7 
%) berbanding subjek kawalan (31.2 ± 8.5%)(p<0.05) dan subjek yang mempunyai 
peratusan lemak tubuh (BIA) lebih daripada 32% berisiko untuk mendapat kanser 
payudara sebanyak 6 kali ganda [OR Kasar =5.9 (95% CI=2.4-14.4)] (p < 0.05) 
berbanding subjek yang mempunyai BIA kurang daripada 32%. 72% daripada subjek 
kanser payudara mengalami obesiti abdominal iaitu nisbah pinggang-pinggul (WHR) 
lebih daripada 0.85 berbanding 22% dalam kalangan subjek kawalan dan hasil kajian 
menunjukkan subjek obesiti abdominal kebarangkalian memiliki 8 kali ganda risiko untuk 
mendapat kanser payudara [OR Kasar= 8.0 (95% CI=3.2-20.4)](p < 0.05) berbanding 
subjek yang mempunyai nisbah pinggang-pinggul kurang daripada 0.85. Pengambilan 
tenaga bagi pesakit kanser payudara (1397.0±311.0 kkal/hari) secara signifikan lebih 
rendah berbanding subjek kawalan (1693.7±379.5 kkal/hari). Pengambilan tenaga 
daripada sumber protein dalam kalangan subjek kanser payudara telah melebihi Saranan 
Pengambilan Nutrien Malaysia (RNI) 2005. Aras hormon leptin dalam kalangan subjek 
kanser payudara (18.1 ± 4.63 ng/ml) secara signifikan lebih tinggi berbanding subjek 
 xv 
 
kawalan (14.7 ± 4.43 ng/ml). Hasil kajian menunjukkan wujud hubungan positif antara 
leptin dan BIA, ukut lilit pinggang dan nisbah pinggang-pinggul. Kesimpulanya, menarki 
awal (sebelum berumur 12 tahun), pos menopaus dan obesiti abdominal meningkatkan 
risko kanser payudara. Aras leptin yang tinggi boleh dijadikan sebagai salah satu 
indikator bagi risiko kanser payudara. 
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ASSOCIATION BETWEEN NUTRITIONAL STATUS AND SERUM LEPTIN 
AMONG NEWLY DIAGNOSED BREAST CANCER PATIENTS IN HOSPITAL 
UNIVERSITI SAINS MALAYSIA (HOSPITAL USM):   
A CASE CONTROL STUDY 
ABSTRACT 
Breast cancer incidences are increasing worldwide.  In Malaysia, the most commonly 
diagnosed cancer among Malaysian women is breast cancer about 29.9% of new cancer 
cases and The National Cancer Registry (2006) reported that there were 3,525 female 
breast cancer cases in Malaysia. Various studies reported that excessive body weight 
might increase the risk of breast cancer and obese people have higher serum leptin level. 
This study was carried out to investigate the relationship between nutritional status and 
serum leptin among newly diagnosed breast cancer patients in Hospital USM. This case 
control study involved 46 newly diagnosed breast cancer patients who were not 
undergone any treatment a n d  4 6  c o n t r o l s  aged between 20-70 years. Informed 
consent was obtained from each study subject. Nutritional parameters used were 
macronutrient intake as assessed by 1-day dietary records(1DDR), anthropometry 
(weight, height, waist & hip circumference,  body mass index, BMI) and body 
composition data (bio-electrical impedance ,BIA). Serum Leptin were measured by 
immunoassay using Human Leptin ELISA Kit (AssayMax Human Leptin, 
Cat.No:EL2001-1; AssayPro, USA). Overall, early menarche were at high risk of getting 
breast cancer by 3 folds [Crude OR 2.9 (95% CI=0.2-1.0)] (p < 0.05) as compared to 
those who were menarche after 12 years old. Being menopause might increase breast 
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cancer risk by 3 folds [Crude OR 3.0 (95% CI=1.2-7.0)] (p < 0.05) when compared with 
pre-menopause study subjects. The BMI of breast cancer patients (24.5 ± 3.8 kg/m2) and 
controls (23.2 ± 4.8kg/m2) were not differed statistically (p>0.05). Percentage of body 
fat (measured by BIA) for cases (36.2 ± 8.7 %) were significantly higher compared with 
controls (31.2 ± 8.5%) (p<0.05) and subjects with BIA more than 32% were at higher 
risk of getting breast cancer by 6 folds [Crude OR =5.9 (95% CI=2.4-14.4)] (p < 0.05) 
compared with subjects BIA less 32%. Furthermore, 72% of breast cancer cases had 
abdominal obesity (WHR more than 0.85) compared to controls (22%) and the study 
result had shown study subjects with abdominal obesity have eight time higher risk of 
getting breast cancer  as compared to those with waist to hip ratio less 0.85 [Crude OR= 
8.0 (95% CI=3.2-20.4)](p < 0.05). Energy intake of cases (1397.0±311.0 kcal/d) were 
significantly lower than controls (1693.7±379.5 kcal/d) (p<0.05).The proportion of 
energy derived from protein in breast cancer cases was higher as the recommended 
nutrient intake for Malaysians (RNI) 2005. Serum leptin level was significantly higher in 
breast cancer cases (18.1 ± 4.63 ng/ml) as compared to controls (14.7 ± 4.43 ng/ml) 
(p<0.05). Positive relationship had been found between serum leptin level and BIA, 
waist and WHR, supporting the evidence that obesity was related to high leptin levels in 
breast cancer. In conclusion, early menarche (before 12 years old), menopause and 
obesity especially abdominal obesity increased breast cancer risk. Serum leptin could be 
an indicator for breast cancer risk. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background 
 
Breast cancer (ICD10: C50) is a cancer that forms in tissues of the breast, usually the 
ducts (tubes that carry milk to the nipple) and lobules (glands that secrete milk). It occurs 
when the cells in the ducts or lobules become abnormal and divide uncontrollably. These 
abnormal cells begin to invade the surrounding breast tissue and may eventually spread 
via blood vessels and lymphatic channels to the lymph nodes, bones, liver, brain and 
lungs. It is common in women compared with men. In the United State, estimated new 
cases and deaths from breast cancer in 2012 are 226,870 (female) and 2,190 (male). This 
cancer cause deaths of 39,510 among female and 410 for male (National Cancer Institute, 
2012). A total of 26,089 cancers were diagnosed among all residents in Peninsular 
Malaysia in the year 2002 and 1 in 4 Malaysians were at great risk to get cancer. Breast 
cancer is the number one cause of cancer deaths in Malaysian women and it accounts for 
30.4% of newly diagnosed cancer cases. The incidence continues to rise as confirmed by 
the second report of Malaysian National Cancer Registry (Lim, Halimah, & Lim, 2003) 
while the actual number of women affected by the disease could be higher than the 
official figures as many women fail to seek treatment for various reasons.  
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The aetiology of breast cancer is not fully understood but there are a number of 
risk factors that can lead to breast cancer. Age at menarche and menopause, diet, 
reproductive history, contraceptive pills, hormonal pills and genetic factors has been 
suggested as risk factor for breast cancer (Knoussi, 2006). One of them also is obesity as 
the prevalence of obesity increasing worldwide and obese women with adult weight gain 
seems to be at increased risk of breast cancer (IARC, 2002). Epidemiologic evidence 
suggested that obesity is associated with increased risk of breast cancer in women (Calle 
and Thun, 2004). Obese women also are susceptible to metabolic syndrome and this in 
turn will put them at higher risk of breast cancer. Women breast cancer patient with high 
BMI (overweight or obese) were 2.5 times as likely to die of their disease within 5 years 
of diagnosis compared with normal BMI patients (Daling, 2001).  
 
According to World Cancer Research Fund (1997), menarche at early age, having 
first pregnancy at late age, late menopause and high body mass index (BMI) and 
overweight were associated with increased breast cancer risk. Hormone replacement 
theraphy, BMI and high fat and high calorie intake will increase the levels of circulating 
free oestrogens (Schairer et al., 2000 &CDC, 2012). Suga et al. (2001) reported that in 
postmenopausal women, BMI correlates with elevated expression of cyclin D1 and bcl2 
mRNA in the mammary tissue, indicating that a high BMI may increase breast cancer risk 
by increasing serum estrogens, modulating cell cycles and inhibiting apoptosis. 
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Leptin is a 167 amino acid protein that is structurally related to members of 
cytokine family (Zhang et al., 1997). Leptin is mainly secreted by the white adipose 
tissue in direct proportion to the amount of energy stored in fat and acts by binding to 
specific protein receptors. Accumulating evidence suggest that the leptin is not mainly an 
“anti-obesity hormone” as proposed originally but is primarily a crucial endocrine factor 
playing an important role in the regulation of several physiological processes. As a 
mitogenic agent, leptin acts to promote cancer growth (Somasundar et al., 2003). 
According to Wu et al., (2004), plasma leptin was significantly positively correlated with 
BMI, waist hip ratio and waist circumference. Excess exposure of mammary epithelium 
to the bioactive substances produced by adipokines at adipose tissue also can contribute 
to breast carcinoma – obesity and leptin is the prominent adipokine. 
 
Nutritional and hormonal factors have been proposed to influence total leptin 
concentration in humans (Friedman et al., 1998). Macronutrients such as carbohydrate, 
fat and protein were found to be associated with obesity and insulin resistance. Few 
studies in breast cancer patients showed a direct relation between high fat intake and 
onset of the disease where the impact of leptin levels on the initiation and progression of 
breast cancer was not addressed (Kabir et al., 2000). The identification of prognostic 
factors in cancer is relevant for the clinical management of the disease. Tumour stage 
remains the single most important prognostic factor in many advanced cancers. However, 
the assessment of nutritional status could be significant in therapeutical strategy 
(Andreoly et al., 2011).  The relation of obesity as one of the risk factor for breast cancer 
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might be due to characterization of obese person such as an increase in adipocyte size and 
number, altered secretion of adipocytokine, and increased angiogenesis. This study was 
aimed to assess serum leptin and nutritional status among newly diagnosed breast cancer       
patients and the result thereafter could be useful for early detection in order to improve 
breast cancer outcome and survival. Prevention and early detection remains the 
cornerstone of breast cancer control. 
 
1.2 Problem Statement 
The most commonly diagnosed cancer among Malaysian women is breast cancer about 
29.9% of new cancer cases and The National Cancer Registry (2006) reported that there 
were 3,525 female breast cancer cases in Malaysia. It is also the most common cancer 
among female and the most important cancer among population regardless of sex in 
Peninsular Malaysia. According to Kelantan Cancer Registry Report (2004-2008), breast 
cancer is the commonest among females with 439 cases with the peak age group was 
between 45-49 years old. The youngest age of breast cancer diagnosed in this study was 
24 years old.  
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Figure 1.1: Female Breast; Age Specific Incidence Rate, Kelantan 2004 – 2009 
[Adapted From: Kelantan Cancer Registry Report 2004 – 2009] 
 
 Excessive body weight and increased serum leptin level are independent risk 
factors for breast cancer patients in Taiwan (Chen et al., 2006). Norsa’adah et al.(2005) 
had found significant risk factors of breast cancer include nulliparity, overweight or 
obesity, family history of breast cancer  and the use of oral contraceptive among Kelantan 
women. But, that particular study did not look at leptin and its relation with nutritional 
status. Rabeta (2008), did a case control study on the relationship between lifestyles, 
obesity, adiponectin level and breast cancer risk, had found that adiponectin was had 
inverse relationship with BMI, waist circumference and body fatness. However, the study 
of the relationship of serum leptin, nutritional status and breast cancer are still lacking in 
this country. Therefore, this study was aimed to investigate the relationship of serum 
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leptin and nutritional status among breast cancer patients and controls. In hope that 
identifying modifiable risk factors can lead to earlier screening and detection of breast 
cancer and help in cancer prevention in this country. 
 
1.3 Objectives 
 1.3.1 General Objective 
To investigate the differences in concentrations of serum leptin and nutritional status in 
newly diagnosed breast cancer patients in Hospital Universiti Sains Malaysia (Hospital 
USM) and healthy women (control). 
 1.3.2 Specific Objectives 
1. To measure and compare the nutritional status based on the data of 
anthropometry, body composition and macronutrient intake among newly 
diagnosed breast cancer patients and control. 
2. To identify the association between serum leptin and anthropometry (Body 
Mass Index, Body Impedance Analysis, and Waist Circumference) among 
breast cancer patients and controls. 
3. To determine the correlation between serum leptin and energy intake 
among breast cancer patients and controls. 
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1.4 Study Hypotheses 
 1. Ho : No difference of  anthropometry, body composition and macronutrient  
 intake among newly diagnosed breast cancer patients and control. 
 2. Ho : No association between serum leptin and anthropometry (BMI, BIA,  
 Waist Circumference) among breast cancer patients. 
 3. Ho : No association between serum leptin and  energy intake among breast  
 cancer patients. 
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Figure 1.2: Conceptual Framework of the Study 
 
Reference: Sahar et al., 2010, Rabeta M.S., 2008 & Chen et al., 2006 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Overview Incidence of Breast Cancer in Malaysia 
The prevalence of Breast Cancer showed an increasing trend around the both developed 
and developing world. In 2012, about 1.7 million people had been diagnosed with breast 
cancer cases (World Cancer Research Fund, 2012). In Malaysia, National Cancer 
Registry (NCR, 2007) reported that about 3242 female breast cancer cases were 
diagnosed compared to 3525 new cases in 2006 (NCR, 2006). Even the number was 
decreased; it was still the most common cancer in females and the first most common 
cancer among population regardless of sex in Malaysia. 
 
2.2 Stages of Breast Cancer 
The early detection of breast cancer is very important in predicting the prognosis of a 
woman with this disease. Patient with late stage of breast cancer are found with larger 
cancer cells and are more likely to have already spread beyond the breast. In contrast, the 
cancer cells that are found during screening mostly are smaller size and still in-situ. There 
are three main activities for breast cancer screening in Malaysia which is Breast Self-
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Awareness (BSA) or previously known as Breast Self-Examination (BSE), Clinical 
Breast Examination (CBE) and mammography screening (Maznah et al., 2011). 
 
 Undetected breast cancer or not treated early, can spread to breast skin and lymph 
nodes. Locally advanced breast cancer (LABC) includes breast cancers with large 
primary tumors of more than 5 cm or those with skin and/or chest wall involvement, and 
with or without regional lymph node involvement (Stage 3a, 3b and 3c).  According to 
Taiplin et al. (2004), 52% of advanced stage of breast cancer cases were related to 
absence during screening programme, 39% related to absence during examination/check-
up and another 8% did not undergo follow up programme. The main problem with the 
implementation of the programme are lack of capital and resources and low educational 
level had caused no mammogram breast screening program for the whole high risk 
women in Malaysia (Abdullah & Yip, 2004). Therefore, the numbers of breast cancer 
patient with late stage are increasing due to late detection. Yip et al. (2006) had found that 
almost 30-40% breast cancer patients in Malaysia were on stage 3 and 4. 
  
Cancer stage is based on the size of the cancer, whether the cancer is invasive or 
non-invasive, whether lymph nodes are involved, and whether the cancer has spread to 
other places beyond the breast. The purpose of the staging system is to help organize the 
different factors and some of the personality features of the cancer into categories in order 
to best understand the prognosis or outcome of the disease, also to guide treatment 
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decisions of patient and help the patients to understand the results of the treatment 
(Breastcancer.org, 2013).  
  
The most common system used to describe the stages of breast cancer is the 
American Joint Committee on Cancer (AJCC) TNM system (American Cancer Society, 
2009). The TNM staging system classifies cancers based on their T, N, and M stages: 
• The letter T followed by a number from 0 to 4 describes the tumor's size 
and spread to the skin or to the chest wall under the breast. Higher T 
numbers mean a larger tumor and/or wider spread to tissues near the 
breast. 
• The letter N followed by a number from 0 to 3 indicates whether the 
cancer has spread to lymph nodes near the breast and, if so, how many 
lymph nodes are affected. 
• The letter M followed by a 0 or 1 indicates whether the cancer has spread 
to distant organs -- for example, the lungs or bones. 
Once the T, N, and M categories have been determined, this information is combined in a 
process called stage grouping.  
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2.2.1: Stage 0 
This is ductal carcinoma in situ (DCIS), a pre-cancer of the breast & lobular carcinoma in 
situ (LCIS) sometimes also is classified as stage 0 breast cancer. In all cases, the cancer 
has not spread to lymph nodes or distant sites. 
2.2.2: Stage I 
i. Stage IA:  
The tumor is 2 cm (about 3/4 of an inch) or less across (T1) and has not spread to lymph 
nodes (N0) or distant sites (M0). 
ii.Stage IB:  
The tumor is 2 cm or less across (or is not found) (T0 or T1) with micro metastases in 1 to 
3 axillary lymph nodes (the cancer in the lymph nodes is greater than 0.2mm across 
and/or more than 200 cells but is not larger than 2 mm)(N1mi). The cancer has not spread 
to distant sites (M0). 
2.2.3: Stage II 
i. Stage IIA:  
One of the following applies: 
 : The tumor is 2 cm or less across (or is not found) (T1 or T0) and either: 
 : It has spread to 1 to 3 axillary lymph nodes, with the cancer in the lymph nodes  
             larger than 2 mm across (N1a), OR 
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 : Tiny amounts of cancer are found in internal mammary lymph nodes on sentinel  
              lymph node biopsy (N1b), OR 
 : It has spread to 1 to 3 lymph nodes under the arm and to internal mammary  
             lymphnodes (found on sentinel lymph node biopsy) (N1c). OR 
 : The tumor is larger than 2 cm but less than 5 cm across (T2) but hasn't spread to  
             the lymph nodes (N0). The cancer hasn't spread to distant sites (M0). 
ii. Stage IIB:  
One of the following applies: 
 : The tumor is larger than 2 cm but less than 5 cm across (T2). It has spread to 1 to  
             3 axillary lymph nodes and/or tiny amounts of cancer are found in internal  
              mammary lymph nodes on sentinel lymph node biopsy (N1). The cancer hasn't  
             spread to distant sites (M0). OR 
 : The tumor is larger than 5 cm across but does not grow into the chest wall or  
               skin and has not spread to lymph nodes (T3, N0). The cancer hasn't spread to  
              distant sites (M0). 
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2.2.4: Stage III 
i. Stage IIIA:  
One of the following applies: 
 : The tumor is not more than 5 cm across (or cannot be found) (T0 to T2). It has  
               spread to 4 to 9 axillary lymph nodes, or it has enlarged the internal mammary  
              lymph nodes (N2). The cancer hasn't spread to distant sites (M0). OR 
 : The tumor is larger than 5 cm across but does not grow into the chest wall or  
               skin (T3). It has spread to 1 to 9 axillary nodes, or to internal mammary nodes  
              (N1 or N2). The cancer hasn't spread to distant sites (M0). 
ii. Stage IIIB: 
The tumor has grown into the chest wall or skin (T4), and one of the following applies: 
           : It has not spread to the lymph nodes (N0). 
            : It has spread to 1 to 3 axillary lymph nodes and/or tiny amounts of cancer are  
              found in internal mammary lymph nodes on sentinel lymph node biopsy (N1). 
 : It has spread to 4 to 9 axillary lymph nodes, or it has enlarged the internal  
             mammary lymph nodes (N2). 
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iii. Stage IIIC:  
Any T, N3, M0: The tumor is any size (or can't be found), and one of the following 
applies: 
: Cancer has spread to 10 or more axillary lymph nodes (N3). 
: Cancer has spread to the lymph nodes under the clavicle (collar bone) (N3). 
: Cancer has spread to the lymph nodes above the clavicle (N3). 
: Cancer involves axillary lymph nodes and has enlarged the internal mammary  
  lymph nodes (N3). 
: Cancer has spread to 4 or more axillary lymph nodes, and tiny amounts of cancer  
  are found in internal mammary lymph nodes on sentinel lymph node biopsy  
  (N3). 
: The cancer hasn't spread to distant sites (M0). 
2.2.5: Stage IV 
Any T, any N, M1: The cancer can be of any size (any T) and may or may not have 
spread to nearby lymph nodes (any N). It has spread to distant organs or to lymph nodes 
far from the breast (M1). The most common sites of spread are the bone, liver, brain, or 
lung. 
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2.3 Breast Cancer Risk Factors 
The risk factors for breast cancer in Western populations had been extensively 
investigated, and it has been suggested that lifestyle-related and reproductive factors were 
strongly associated with breast cancer (Norsa’adah et al., 2005). All women should 
understand the risk factor and update knowledge regarding breast cancer. Norsa’adah et 
al. (2005) had found that similar risk factor identified in Western populations were 
responsible for the occurrence of breast cancer in Kelantan. However, the information 
regarding risk factor of breast cancer is still low among Asian women.    
  
There were numerous risk factors that can contribute to breast cancer and it can be 
divided into preventable and non-preventable. Some examples of non-preventable risk 
factors were genetic, breast density, reproductive history, family history, age and prior 
breast procedure. While, preventable risk factors were dietary habits, obesity, alcohol use 
and physical activity.  Some of the breast cancer risks have a different role among pre 
menopause and post menopause women. In both premenopausal and postmenopausal 
women cancer risk is associated with events that alter hormonal balance, such as age at 
menarche, parity, body weight, body fat distribution, and use of exogenous hormones 
(Hong et al., 2004).  
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2.3.1 Preventable Risk Factors 
Preventable risk factors are the risks that can be controlled. Many epidemiological studies 
have looked at the relationship between behavior and lifestyle variables on the incidence 
of breast cancer (Lemon et al., 2004).  
 
2.3.1.1 Overweight and obesity 
Dietary habit and lifestyle change have resulted in an increased number of obese people. 
Obesity is a condition in which a person has an abnormally high and unhealthy proportion 
of body fat. World Health Organization (WHO) defines obesity in terms of a scale known 
as the body mass index (BMI). BMI provides a more accurate measure of obesity or being 
overweight than weight alone (King, 2011). High BMI is generally interpreted as excess 
adiposity (overweight or obesity). Obesity is related to many life-threatening diseases 
such as cancer diabetes and cardiovascular disease. It also contributes to an acceleration 
of the aging process, shortening of the lifespan, depression, and a decrease in quality of 
life (Romao et al., 2008).  
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Figure 2.1. Diseases and conditions associated with obesity (body mass index ≥30; 
calculated as kg/m2). [Adapted from: Romao,et al., 2008.] 
 
 Obesity is a major health problem and is positively associated with breast cancer 
incidence and mortality (Barnett, 2003, Lorincz & Sukumar 2006). WCRF concluded that 
the associations between BMI and incidence of breast cancer were due to body fatness. 
The WCRF review panel concluded that weight is a factor that convincingly leads to an 
increase in breast cancer risk in postmenopausal women (World Cancer Research Fund, 
2004) and this also has been supported by James et al., (2015) when they found high body 
mass index (BMI) is associated with increased risk of post-menopausal breast cancer and 
with poorer outcome in those with a history of breast cancer.   
  
 
 19 
 
Relationship between breast cancer and obesity is not in a direct proportion 
(Carmichael & Bates, 2004). However, the mechanism of body weight affected breast 
cancer involved complex interactions between obesity, tumor biology and physiological 
function of the breast (Rose et al., 2002).  
  
Body composition mainly consists of two components which is adipose tissue and 
fat free mass. This classification focused on fat because usually fat mass become main 
issue in health (Brodie et al., 1998).  
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Body Composition Components 
[Source: Willet, 1998] 
• Muscle 
• Bones 
• Water 
• Others  
Body Mass 
Adipose Fat Free Mass 
(FFM) 
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 Body composition is often defined as the ratio of fat to fat free mass and 
frequently is expressed as a percentage of body fat. Table 2.1 shows body fat range for 
persons 18 years of age and older. 
 
Table 2.1 Body fat range for persons 18 years of age and older. 
Classification Males Females 
Unhealthy range (too low) ≤ 5% ≤ 8% 
Acceptable range (lower 
end) 
6-15% 9-23% 
Acceptable range (upper 
end) 
16-24% 24-31% 
Unhealthy (too high) ≥ 25% ≥ 32% 
[Source: Lee & Nieman (2007)] 
 
i. Adipose Tissue (Fat storage)  
The main role of adipose tissue is to store energy in the form of fat. However, it also 
provides cushions and insulates the body. Recently, research has found adipose tissue also 
act as endocrine organ. Adipose tissue is a source of estrogens, insulin and insulin-like 
growth factors, all of which are believed to be involved in mammary tumorigenesis and 
have been extensively evaluated as breast cancer markers and therapeutic targets 
(Surmacz, 2007).  
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 Several possible mechanisms have been suggested to explain the association of 
obesity with increased risk of breast cancer. One of them is excess amounts of estrogen 
production by fat cells.  The increased risk of postmenopausal breast cancer is thought to 
be due to increased levels of estrogen in obese women. After menopause, when the 
ovaries stop producing hormones, fat tissue becomes the most important source of 
estrogen. Because obese women have more fat tissue, their estrogen levels are higher, 
potentially leading to more rapid growth of estrogen-responsive breast tumors (James, 
2015 & American Cancer Society, 2009).  
 
 Obese postmenopausal women have increased circulating insulin levels. Insulin 
stimulates the growth of breast-cancer cell lines and may increase breast cancer risk 
(Kaaks, 1996). Insulin-like growth factors (IGFs) are peptides that help regulate tissue 
growth and fat deposition (Stoll, 2000). One of these, IGF-1, stimulates mitosis in breast 
cancer cells. IGF-1 levels may be higher among obese women (Lipworth, 1996).  
 
ii. Fat Free Mass 
Fat free mass (FFM) is the amount of lean body. It is composed of muscle, water, bone, 
and other tissues devoid of fat and lipid (Lee & Nieman, 2007).  
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iii. Leptin  
Fat cells produce hormones, called adipokines that may stimulate or inhibit cell growth 
(Jarde, 2011). The plasma leptin concentrations increased in direct proportion to the 
adipose mass (Zhang et al., 2005). These two hormones were leptin and adiponectin. 
Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved 
in the regulation of food intake and energy balance. It is more abundant in obese people, 
seems to promote cell proliferation, whereas adiponectin, which is less abundant in obese 
people, may have antiproliferative effects (Garotalo, 2006). Jarde (2011) had found leptin 
also secreted by epithelial tissue of breast tumor. Recent evidence suggests that leptin also 
plays an important role in normal mammary development and mammary tumor 
formation. Perrera (2008) suggested that leptin promotes mammary tumor growth through 
multiple mechanisms, including regulating the cell cycle, apoptosis, and by modulating 
the extracellular environment. There is increasing evidence that targeting the 
adiponectin:leptin ratio might be a new prognostic and/or therapeutic strategy for 
postmenopausal breast cancer (Jarde, 2011). Wu (2009) has shown that leptin was 
correlated with breast cancer risk. 
 
2.3.1.2 Diet 
There are a few dietary factors related to breast cancer risk. Among them are fiber intake 
and dietary fat. Unraveling links between diet and cancer is complex, as thousands of 
dietary components are consumed each day; a typical diet may provide more than 25000 
bioactive food constituents (FAO, 2003). As shown in Figure 2.3, food can influence 
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fundamental processes which may promote or inhibit cancer development and 
progression at various ways such as metabolism of carcinogenic substances in food, 
apoptosis, DNA repair and hormonal regulation.  
 
 
 
 
 
 
 
 
Figure 2.3: Influence of food, nutrition, obesity, and physical activity on 
fundamental processes shown here, which may promote or inhibit cancer 
development and progression 
[Source: World Cancer Research Fund and  
American Institute for Cancer Research, 2007] 
 
 i. Excessive fat intake 
Dietary fat is a macronutrient that provides energy for human body. Fat is high in calories 
and with small amounts can add up energy quickly. Excessive calorie intake will lead to 
weight gain and excessive weight is linked to risk of breast cancer. Excessive fat intake 
which is more than necessary for the formation of membranes and energy needs will be 
stored in adipose tissue and this will lead to obesity (Nik Nawal, 1998). Mattison (2004) 
Food, Nutrition,Obesity,Physical Activity and Cellular Processes Linked to 
cancer 
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had showed statistically significant increased risk of breast cancer with increasing fat 
intake.  
  
 Dietary fat is relatively well established as a cause of increased endogenous 
estrogen production (Wu, 1999). Higher endogenous estrogen levels after menopause are 
a known cause of breast cancer (Key, 2002). Low-fat diets are usually associated with 
high fiber intake, which may reduce estrogen concentration by decreasing intestinal 
reabsorption. Another alternative mechanism by which dietary fat could influence steroid 
hormone levels is that increased serum-free fatty acids could displace estradiol from 
serum albumin, thus increasing free estradiol concentration (Burning, 1986). Sex 
hormone binding globulin decreases with increasing body mass index and insulin 
resistance. Other important factor that related with fat is energy-dense lower the age of 
menarche and early menarche is an established risk factor for breast cancer (American 
Cancer Society, 2007). 
 
ii. Lack of fiber  
Dietary fiber is all parts of plant foods that cannot be digested or absorbed by human 
body. Fiber can provide many health benefits such as helping to maintain a healthy 
weight and lower risk of diabetes, cancer and heart disease. Aune (2011) suggested that 
diets rich in fiber are associated with reduced breast cancer risk. Dietary fiber has been 
hypothesized to reduce breast cancer risk based on observations that vegetarian women 
